Medicina
Departamento
University of Texas Health Science Center at San Antonio
San Antonio, Estados UnidosPublicaciones en colaboración con investigadores/as de University of Texas Health Science Center at San Antonio (27)
2023
2022
-
Elacestrant (oral selective estrogen receptor degrader) Versus Standard Endocrine Therapy for Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Results From the Randomized Phase III EMERALD Trial
Journal of Clinical Oncology, Vol. 32
-
Optical coherence tomography in coronary atherosclerosis assessment and intervention
Nature Reviews Cardiology, Vol. 19, Núm. 10, pp. 684-703
-
Phase I/II study of the LAG-3 inhibitor ieramilimab (LAG525) ± anti-PD-1 spartalizumab (PDR001) in patients with advanced malignancies
Journal for immunotherapy of cancer, Vol. 10, Núm. 2
-
Secukinumab demonstrates efficacy, safety, and tolerability upon administration by 2 ml autoinjector in adult patients with plaque psoriasis: 52-week results from MATURE, a randomized, placebo-controlled trial
Dermatologic Therapy, Vol. 35, Núm. 3
2021
-
Aspiration Risk Factors, Microbiology, and Empiric Antibiotics for Patients Hospitalized With Community-Acquired Pneumonia
Chest, Vol. 159, Núm. 1, pp. 58-72
-
Global guideline for the diagnosis and management of rare yeast infections: an initiative of the ECMM in cooperation with ISHAM and ASM
The Lancet Infectious Diseases, Vol. 21, Núm. 12, pp. e375-e386
2020
-
Correction to: Atypical pathogens in hospitalized patients with community-acquired pneumonia: a worldwide perspective (BMC Infectious Diseases, (2018), 18, 1, (677), 10.1186/s12879-018-3565-z)
BMC Infectious Diseases
-
Standard anthracycline based versus docetaxel-capecitabine in early high clinical and/or genomic risk breast cancer in the EORTC 10041/BIG 3-04 MINDACT phase III trial
Journal of Clinical Oncology, Vol. 38, Núm. 11, pp. 1186-1197
2019
-
An international perspective on hospitalized patients with viral community-acquired pneumonia
European Journal of Internal Medicine, Vol. 60, pp. 54-70
-
International prevalence and risk factors evaluation for drug-resistant Streptococcus pneumoniae pneumonia
Journal of Infection, Vol. 79, Núm. 4, pp. 300-311
-
Prevalence and etiology of community-acquired pneumonia in immunocompromised patients
Clinical Infectious Diseases, Vol. 68, Núm. 9, pp. 1482-1493
2018
-
Burden and risk factors for Pseudomonas aeruginosa community-acquired pneumonia: A multinational point prevalence study of hospitalised patients
European Respiratory Journal, Vol. 52, Núm. 2
-
Corticosteroid treatment in critically ill patients with severe influenza pneumonia: a propensity score matching study
Intensive Care Medicine, Vol. 44, Núm. 9, pp. 1470-1482
-
Microbiological testing of adults hospitalised with community-acquired pneumonia: An international study
ERJ Open Research, Vol. 4, Núm. 4
2016
-
Global initiative for meticillin-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort study
The Lancet Infectious Diseases, Vol. 16, Núm. 12, pp. 1364-1376
-
Procalcitonin (PCT) levels for ruling-out bacterial coinfection in ICU patients with influenza: A CHAID decision-tree analysis
Journal of Infection, Vol. 72, Núm. 2, pp. 143-151
2011
-
A prospective rAnDomised study of a rotary powered device (OnControl) for Bone marrow aspiration and biopsy
Journal of Clinical Pathology, Vol. 64, Núm. 9, pp. 809-813
-
Analysis of the influence of PTPN22 gene polymorphisms in systemic sclerosis
Annals of the Rheumatic Diseases, Vol. 70, Núm. 3, pp. 454-462
2010
-
BANK1 functional variants are associated with susceptibility to diffuse systemic sclerosis in Caucasians
Annals of the Rheumatic Diseases, Vol. 69, Núm. 4, pp. 700-705